| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 03/10/2010 | CN101668777A Activation of human antigen-presenting cells through clec-6 |
| 03/10/2010 | CN101664545A Therapies for renal failure using interferon-beta |
| 03/09/2010 | US7674752 Functional protein arrays |
| 03/09/2010 | US7674585 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation |
| 03/09/2010 | US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis |
| 03/03/2010 | CN101659704A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists |
| 03/02/2010 | US7671175 animal feed additive; detergent; defensins; exhibit reduced hemolytic activity, cytotoxicity and sensitivity towards cations, such as Ca2+, Mg2+, Na+. |
| 03/02/2010 | US7671028 Peptides that antagonize FPR class receptor mediated signaling |
| 03/02/2010 | US7670817 Dynamin mediated diseases and associated methods and products |
| 02/25/2010 | US20100048876 Chromatography ligand comprising domain c from staphylococcus aureus protein a for antibody isolation |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1471936B1 Hiv vaccine and method of use |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor |
| 02/23/2010 | US7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 02/23/2010 | US7666400 PEGylation by the dock and lock (DNL) technique |
| 02/18/2010 | WO2010018859A1 Modified biotin-binding protein |
| 02/18/2010 | US20100041127 Preparation and use of a reactive solid support surface |
| 02/18/2010 | US20100040644 Methods for preparing immunogenic conjugates |
| 02/18/2010 | CA2733545A1 Modified biotin-binding protein |
| 02/17/2010 | EP2154535A1 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2010 | EP2154160A1 Hydroxyalkyl starch derivatives |
| 02/17/2010 | EP2154154A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 02/16/2010 | US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy |
| 02/16/2010 | US7662924 Beta chain-associated regulator of apoptosis |
| 02/16/2010 | US7662919 Notch-based fusion proteins and uses thereof |
| 02/16/2010 | US7662911 Adjacent hybrid peptide layers covalently bonded by a non-peptidic linkage; improved biofunctionality; drug delivery microcapsules; improved drug retention during fabrication |
| 02/11/2010 | WO2010017412A1 Novel biomimetic peptoid polymers |
| 02/11/2010 | WO2010015022A1 Antigen-presenting scaffolds |
| 02/11/2010 | US20100036102 Novel chelating agents and highly luminescent and stable chelates and their use |
| 02/11/2010 | CA2733006A1 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 02/11/2010 | CA2733005A1 Truncated analogues of glucose-dependent insulinotropic polypeptide |
| 02/11/2010 | CA2732973A1 Glucose-dependent insulinotropic polypeptide analogues |
| 02/11/2010 | CA2732949A1 Analogues of glucose-dependent insulinotropic polypeptide |
| 02/09/2010 | US7659374 Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 02/09/2010 | US7659373 Producing such EPO products characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure |
| 02/09/2010 | US7659240 Mucin immobilized chromatography |
| 02/09/2010 | CA2350417C Dna-protein fusions and uses thereof |
| 02/04/2010 | US20100028950 Method for the immobilization of biologically active polypeptides by using maltose binding protein |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/03/2010 | CN101638439A Material and method for removing harmful substance |
| 02/02/2010 | US7655752 TNF-α converting enzyme inhibitory agents and method of using same |
| 02/02/2010 | US7655751 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 02/02/2010 | US7655472 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer |
| 02/02/2010 | US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 02/02/2010 | US7655410 Using concentration of human luteinizing hormone (hLH) to prognose and predict onset of menopause; evaluating efficacy of hormone replacement therapy |
| 02/02/2010 | US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | CA2302779C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 01/28/2010 | WO2009148549A3 Novel biosensors for live cell imaging of intracellular proteins |
| 01/28/2010 | WO2009009767A3 New bacillus thuringiensis toxin |
| 01/28/2010 | US20100022443 Derivatisation of erythropoietin (epo) |
| 01/28/2010 | US20100022441 N-terminal polysialylation |
| 01/28/2010 | US20100022438 Method of separating carbon nanotubes |
| 01/28/2010 | US20100021489 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
| 01/26/2010 | CA2419490C Functional protein arrays |
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/21/2010 | WO2010007723A1 Peptide capable of binding to ceramic material |
| 01/21/2010 | WO2009130612A3 Prion epitopes and methods of use thereof |
| 01/21/2010 | WO2004041170A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | US20100016562 Reducing the immunogenicity of fusion proteins |
| 01/21/2010 | US20100016549 Peyer's patch and/or m-cell targeting ligands |
| 01/21/2010 | US20100015163 Dendritic cell potentiation |
| 01/20/2010 | EP1599227B1 Methods of immunomodulation in animals |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7648701 Peptide composition as immunogen for the treatment of allergy |
| 01/14/2010 | WO2003083054A9 Amylases, nucleic acids encoding them and methods for making and using them |
| 01/14/2010 | US20100009438 Dendritic cell potentiation |
| 01/14/2010 | US20100008920 Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors |
| 01/13/2010 | EP2143736A1 Hydroxyalkyl starch derivatives |
| 01/13/2010 | EP2142571A2 Pp1 ligands |
| 01/12/2010 | CA2309604C Compositions and methods for targeted delivery of factors |
| 01/07/2010 | WO2010000061A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
| 01/07/2010 | WO2009126616A3 Thrombin activator compostions and methods of making and using the same |
| 01/06/2010 | EP2141243A2 Protein scaffolds for antibody mimics and other binding proteins |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642235 Macrocyclic peptides active against the hepatitis C virus |
| 01/05/2010 | US7642085 Polypeptide incorporating unnatural amino acid chemically bonded to solid support by a chemical linkage |
| 01/03/2010 | CA2653866A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
| 12/31/2009 | US20090325262 Immobilization of biological molecules onto surfaces coated with monolayers |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090321357 Affinity Particle And Affinity Separation Method |
| 12/30/2009 | WO2009158657A2 Molecularly imprinted polymers for detecting microorganisms |
| 12/30/2009 | WO2009155937A1 Carriers for immobilization and reuseability of enzymes |
| 12/30/2009 | WO2009117473A3 Structures including antimicrobial peptides |
| 12/30/2009 | WO2009078977A9 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 12/29/2009 | US7638485 Modulating apoptosis |
| 12/29/2009 | US7638289 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 12/29/2009 | US7638279 Preferential nucleotide sequences for use in in the detection, quantitation and/or analysis of nucleic acids |
| 12/29/2009 | US7638131 Coccidiosis poultry vaccine |
| 12/24/2009 | US20090318672 Antibodies to pro352 |
| 12/23/2009 | CN101611052A Multimeric FC receptor polypeptides including a modified FC domain |
| 12/23/2009 | CA2852177A1 Glucagon/glp-1 receptor co-agonists |
| 12/22/2009 | US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 12/22/2009 | US7635675 Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 12/22/2009 | US7635573 terminal peptide selection for comparing protein levels in two or more samples by differentially isotopically labeling each sample's proteins' N- or C-termini; quantitative analysis; comparision; analysis on proteomic sample |
| 12/22/2009 | US7635478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/22/2009 | CA2133833C Method and kit for imaging and treating organs and tissues |
| 12/17/2009 | WO2009151633A1 Novel monoclonal antibodies against hpv proteins |